JMB-HEADER RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG

YearIMPACT-FACTOR
2022  1,200
2021  1,540
2020  1,374
2019  1,023
2018  0,932
2017  0,977
2016  0,799
2015  0,662
2014  0,740
2013  0,739
2012  0,637
2011  0,658
2010  0,654
2009  0,570
2008  0,849
2007  0,805
2006  0,330
2005  0,435
2004  0,623
2003  0,567
2002  0,641
2001  0,490
2000  0,477
1999  0,762
1998  0,785
1997  0,507
1996  0,518
1995  0,502
Vol 50(2016) N 6 p. 927-929; DOI 10.1134/S0026893316060091 Full Text

S.A. Khmeleva1,2, S.A. Kozin1, Y.Y. Kiseleva2, V.A. Mitkevich1, A.A. Makarov1, S.P. Radko1,2*

Zinc-induced interactions of the metal-binding domain of beta-amyloid with nucleic acids and glycosaminoglycans

1Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991
2Orekhovich Institute of Biomedical Chemistry, Moscow, 119121

*radkos@yandex.ru
Received - 2016-02-03; Accepted - 2016-03-05

Zinc ions form complexes with β-amyloid peptides and play an important role in Alzheimer's disease pathogenesis. It has been demonstrated by turbidimetry and correlation spectroscopy that synthetic peptide Aβ16 representing the metal-binding domain of β-amyloid is able to interact with nucleic acids, chondroitin polysulfate, and dextran sulfates in the presence of zinc ions. The amino acid D7H substitution enhanced the peptide binding to polyanions, whereas the H6R and H6A-H13A substitutions abolished this interaction. It is suggested that the metal-binding domain may serve as a zinc-dependent site of β-amyloid interaction with biological polyanions including DNA, RNA, and glycosaminoglycans.

Alzheimer disease, beta-amyloid, zinc, nucleic acids, glycosaminoglycans



JMB-FOOTER RAS-JOURNALS